Mostrar el registro sencillo del ítem

dc.contributor.authorGalindo-Zavala, Rocío
dc.contributor.authorBou-Torrent, Rosa
dc.contributor.authorMagallares-López, Berta
dc.contributor.authorMir-Perelló, Concepción
dc.contributor.authorPalmou-Fontana, Natalia
dc.contributor.authorSevilla-Pérez, Belén
dc.contributor.authorMedrano-San Ildefonso, Marta
dc.contributor.authorGonzález-Fernández, Mª Isabel
dc.contributor.authorRomán-Pascual, Almudena
dc.contributor.authorAlcañiz-Rodríguez, Paula
dc.contributor.authorNieto-Gonzalez, Juan Carlos
dc.contributor.authorLópez-Corbeto, Mireia
dc.contributor.authorGraña Gil, Genaro 
dc.date.accessioned2022-03-16T08:37:37Z
dc.date.available2022-03-16T08:37:37Z
dc.date.issued2020
dc.identifier.issn1546-0096
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32093703es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16259
dc.description.abstractBACKGROUND: Osteoporosis incidence in children is increasing due to the increased survival rate of patients suffering from chronic diseases and the increased use of drugs that can damage bones. Recent changes made to the definition of childhood osteoporosis, along with the lack of guidelines or national consensuses regarding its diagnosis and treatment, have resulted in a wide variability in the approaches used to treat this disease. For these reasons, the Osteogenesis Imperfecta and Childhood Osteoporosis Working Group of the Spanish Society of Pediatric Rheumatology has sounded the need for developing guidelines to standardize clinical practice with regard to this pathology. METHODS: An expert panel comprised of 6 pediatricians and 5 rheumatologists carried out a qualitative literature review and provided recommendations based on evidence, when that was available, or on their own experience. The level of evidence was determined for each section using the Oxford Centre for Evidence-based Medicine (CEBM) system. A Delphi survey was conducted for those recommendations with an evidence level of IV or V. This survey was sent to all members of the SERPE. All recommendations that had a level of agreement higher or equal to 70% were included. RESULTS: Fifty-one recommendations, categorized into eight sections, were obtained. Twenty-four of them presented an evidence level 4 or 5, and therefore a Delphi survey was conducted. This was submitted electronically and received a response rate of 40%. All recommendations submitted to the Delphi round obtained a level of agreement of 70% or higher and were therefore accepted. CONCLUSION: In summary, we present herein guidelines for the prevention, diagnosis and treatment of secondary childhood osteoporosis based on the available evidence and expert clinical experience. We believe it can serve as a useful tool that will contribute to the standardization of clinical practice for this pathology. Prophylactic measures, early diagnosis and a proper therapeutic approach are essential to improving bone health, not only in children and adolescents, but also in the adults they will become in the future.en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshCalcium*
dc.subject.meshGlucocorticoids*
dc.subject.meshOsteoporotic Fractures*
dc.subject.meshCystic Fibrosis*
dc.subject.meshMetabolism*
dc.subject.meshKidney Diseases*
dc.subject.meshDiphosphonates*
dc.subject.meshBone Density Conservation Agents*
dc.subject.meshRadiotherapy*
dc.subject.meshHumans*
dc.subject.meshEndocrine System Diseases*
dc.subject.meshAutoimmune Diseases*
dc.subject.meshIatrogenic Disease*
dc.subject.meshHematologic Diseases*
dc.subject.meshNeuromuscular Diseases*
dc.subject.meshVitamin D*
dc.subject.meshPractice Guidelines as Topic*
dc.subject.meshOsteoporosis*
dc.subject.meshEpidermolysis Bullosa*
dc.subject.meshHIV Infections*
dc.titleExpert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in childrenen
dc.typeJournal Articlees
dc.authorsophosGalindo-Zavala, Rocío;Bou-Torrent, Rosa;Magallares-López, Berta;Mir-Perelló, Concepción;Palmou-Fontana, Natalia;Sevilla-Pérez, Belén;Medrano-San Ildefonso, Marta;González-Fernández, Mª Isabel;Román-Pascual, Almudena;Alcañiz-Rodríguez, Paula;Nieto-Gonzalez, Juan Carlos;López-Corbeto, Mireia;Graña-Gil, Jenaro
dc.identifier.doi10.1186/s12969-020-0411-9
dc.identifier.pmid32093703
dc.identifier.sophos36106
dc.issue.number1es
dc.journal.titlePediatric Rheumatologyes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Reumatoloxíaes
dc.relation.publisherversionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041118/pdf/12969://2020://Article://411.pdfes
dc.rights.accessRightsopenAccess
dc.subject.decsenfermedades renales*
dc.subject.decsosteoporosis*
dc.subject.decsconservadores de la densidad ósea*
dc.subject.decsglucocorticoides*
dc.subject.decsguías de práctica clínica como asunto*
dc.subject.decsinfecciones por VIH*
dc.subject.decsepidermolisis ampollosa*
dc.subject.decsmetabolismo*
dc.subject.decsradioterapia*
dc.subject.decsenfermedades neuromusculares*
dc.subject.decsenfermedades hematológicas*
dc.subject.decsfracturas osteoporóticas*
dc.subject.decsdifosfonatos*
dc.subject.decshumanos*
dc.subject.decsenfermedades del sistema endocrino*
dc.subject.decsvitamina D*
dc.subject.decsfibrosis quística*
dc.subject.decsenfermedad iatrogénica*
dc.subject.decsenfermedades autoinmunes*
dc.subject.decscalcio*
dc.subject.keywordCHUACes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number18es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional